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Tuberculosis is a leading cause of death worldwide. It affects pulmonary and extra-pulmonary sites with
a multitude of differing presentations. In this report, we describe two cases in which TB causes myo-
pericarditis and presents with a broad-complex tachycardia that did not respond typically to standard
anti-arrhythmic therapy; a very rare presentation with limited description in the literature. Both patients
required extensive investigation culminating in identifying lymph nodes amenable to biopsy under
endobronchial ultrasound guidance. It was not until both patients received anti-tuberculous chemo-
therapy alongside anti-arrhythmic management that any improvement to their condition was witnessed.
Therefore, we recommend that the clinician should have a high index of suspicion for TB in any patient
presenting with a broad-complex tachycardia that is not responding to standard ﬁrst line management,
especially if the patient is from a high risk background. We recommend an active diagnostic pursuit, and
lymph node biopsy under endobronchial ultrasound guidance.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.Case one
A previously ﬁt and well 38 year-old gentleman, originally from
India presented with palpitations and chest pain. His electrocar-
diogram showed ventricular tachycardia with 1 mm ST elevation in
V1, V2 and aVL. The troponin-I was elevated at 0.27 ug/L. He was
cardioverted with amiodarone, and then transferred for Primary
Coronary Intervention, which showed normal, right dominant
arteries.
An echocardiogram showed a mildly dilated left ventricle with
basal anteroseptal akinesis/myocardial thinning with moderate
overall systolic impairment. A cardiac magnetic resonance (CMR)
scan showed pericardial enhancement and an enlargedmediastinal
lymph node suggesting myopericarditis or sarcoidosis. A computed
tomography (CT) scan of the thorax, abdomen and pelvis showed
right apical scarring with associated pretracheal and subcarinal
lymphadenopathy, raising the possibility of tuberculosis.
A cardiac biopsy was performed but the samples were incon-
clusive with no features of myocarditis or granulomas. Acid fast
bacilli (AFB) were not cultured.x: þ44 203 312 1613.
wford@imperial.nhs.uk, onn.
Ltd.Open access under CC BY-NC-ND He developed a global pericardial effusion that required peri-
cardiocentesis and drainage. The blood stained pericardial ﬂuid
showed mildly increased neutrophils, macrophages and mesothe-
lial cells. Fluid was negative for bacteria, fungi, AFB, malignant cells
and granulomata.
Prior to discharge, an implantable cardioverter-deﬁbrillator
(ICD) was inserted alongside commencing amiodarone and
bisoprolol.
Outpatient investigations included reactive TB-ELISPOT tests
further raising the suspicion of TB. On ultrasound he had an
enlarged right cervical lymph node which was biopsied, showing
necrotising granulomatous inﬂammation but no organisms. His
pretracheal and subcarinal lymphadenopathy were sampled via
endobronchial ultrasound (EBUS). A trans-bronchial biopsy showed
non-necrotising granulomas with a negative TB Polymerase Chain
Reaction (PCR). However after 16 days, a fully sensitive Mycobac-
terium Tuberculosis was ﬁnally cultured, providing the ﬁnal diag-
nosis. He subsequently commenced six months of quadruple anti-
tuberculous treatment. He remains under cardiology and respira-
tory follow-up.
Case two
A 25 year-old Asian gentleman presented with intermittent
chest pain at rest and palpitations. He was morbidly obese with
well-controlled asthma, smoking two cigarettes daily. Hislicense.
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with a positive Troponin-I of 0.099 ug/L. Coronary angiography
showed unobstructed coronaries. Post procedure he had short ep-
isodes of a narrow complex tachycardia, which settled with biso-
prolol. An echocardiogram showed good overall systolic function.
He was discharged with outpatient follow-up.
He re-presented three weeks later with progressive dyspnoea.
An echocardiogram demonstrated a severe cardiomyopathy with
signiﬁcantly impaired left ventricular function (ejection fraction
33%) and an associated stage 1 diastolic dysfunction. Electrocardi-
ography detected a sustained monomorphic broad complex
tachycardia. Electrophysiological study was unremarkable.
An endomyocardial biopsy was performed, revealing areas of
myocyte loss and destruction associated with an inﬂammatory cell
inﬁltrate including giant cells, lymphocytes, histiocytes and occa-
sional eosinophils. Granulomas were not identiﬁed. Pathology
interpreted these changes as a giant cell myocarditis, for which he
received a 3-day course of anti-thymocyte globulin and was
commenced on oral prednisolone at a daily dose of 1 mg/kg. An ICD
was also inserted.
Owing to his body habitus CMR was not possible. Thoracic and
abdominal CT-scan demonstrated signiﬁcant lymphadenopathy. He
proceeded to positron emission topography (PET), showing PET-
avid lymphadenopathy in the right paratracheal and subcarinal
regions. A TB-Elispot interferon gamma-release assay was reactive.
A mantoux test was similarly positive (16 mm). His LDH however,
was elevated at 325 IU/L. The differential diagnosis included both
lymphoma and tuberculosis.
He underwent an EBUS biopsy of his right peribronchial lymph
node, showing non-necrotising granulomas and a negative TB-PCR.
However after 18 days, the culture grew M. tuberculosis, ﬁnally
conﬁrming the diagnosis. He therefore commenced anti-
tuberculosis therapy for six months, while continuing predniso-
lone. Following four months of steroid and TB treatment his ven-
tricular function showed signiﬁcant improvement. A repeat cardiac
biopsy showed resolving inﬂammation with re-organisation of the
myocardium, suggesting a response to the combination of TB
treatment and immunosuppression. It remains unclear as to
whether there was a degree of TB myocarditis underlying his initial
presentation. He remains under cardiology and respiratory follow-
up.
Discussion
M. tuberculosis (TB) is a leading cause of death worldwide. The
latest WHO report states that there were 9.4 million new cases of,
and 1.7 million deaths caused by TB in 2009 [1]. The 21st century
has witnessed growing challenges in the ongoing battle against TB.
Human immunodeﬁciency virus, the increased use of immuno-
suppressive medications, and the emergence of multi and
extremely drug resistant mycobacterium infections have created an
evolving and new climate of complexity in the management of this
pandemic [2]. However, what remains unchanged is the multitude
of diverse TB presentations.
TB most commonly infects the pulmonary system [3]. The most
frequently affected extra-pulmonary sites are the abdomen, lymph
nodes and central nervous system. The cardiovascular system is
only rarely involved with the pericardium being most susceptible.
Myocardial, endocardial, valvular and coronary arterial involve-
ment is extremely uncommon. Cardiac tuberculosis deserves a
special mention due to its potential to cause sudden cardiac death
(SCD) secondary to tachyarrhythmia [4], or the development of
pericardial effusions and tamponade.
In this report, we describe TB presenting as a sustained mono-
morphic ventricular tachycardia (SMVT): a phenomenon that hasvery limited description in the literature. Liu et al. 2012 review the
association between cardiac tuberculosis and SCD, emphasising
that this is a diagnosis conﬁrmed on post mortem [5]. This high-
lights the importance of considering tuberculosis early in a patient
with a susceptible background and symptoms not responding to
gold-standard management [4].
Thachill et al., 2011 describe 14 cases of SMVT with preserved
ventricular function that responded poorly to radiofrequency
ablation. These patients underwent CMR, PET and cardiac perfusion
scans to investigate an alternative diagnosis. Signiﬁcant lymph-
adenopathy became apparent, raising the possibility of TB or
sarcoidosis. In select cases endomyocardial biopsies were per-
formed to seek a histopathological diagnosis and tissue for TB
culture [6]. The importance of searching for lymphadenopathy is
highlighted in this study whereby even in those patients without
cardiac inﬂammation on CMR, mediastinal nodes were found on
PET. With our second patient, it was only upon PET scanning that
we found right paratracheal and subcarinal lymphadenopathy.
Thachill et al., 2011 [6] and Koplan et al., 2006 [7] describe a VT
recurrence rate of 100% in patients receiving only anti-
arrhythmics and radiofrequency ablation. Recurrence was signif-
icantly reduced from “6.5 VTs/patient-year to 0.6 VTs/patient-year”
by introducing disease-speciﬁc therapy [6]. In both our patients,
treatment consisted of antiarrhythmic drugs, quadruple anti-
tuberculous medication and the implantation of an ICD, with
successful outcome.
Interestingly, in both patients there was predominance of right-
sided signs including right paratracheal lymphadenopathy or right
apical scarring suggestive of old TB. It is proposed that TB
myocarditis arises from three possible routes of spread: direct
infection from the pericardium, haematogenous seeding, or
through lymphatic spread. The case report by Khurana et al., 2007,
in agreement with Maeder et al., 2003 [8] suggests that there may
be an anatomical predilection to the right-sided mediastinal lymph
nodes “making the right side of the heart the most vulnerable area of
the myocardium owing to the potential for direct spread” [9]. Further
investigation is necessary to determine whether this is a true as-
sociation or coincidental.
A further consideration is whether the TB could be a bystander
in our second case. The presenting features included a dysrhythmia
and severe cardiomyopathy with signiﬁcantly impaired left ven-
tricular function, which dramatically improved following the
introduction of anti-tuberculous medication. The case report by
Everett et al. in 2013 suggests that in our second case, the primary
diagnosis was that of giant cell myocarditis, rather than TB
myocarditis as we speculate here [10]. The report suggests that it
was only once the patient was subjected to immunosuppression
that latent TBwas reactivated. Even if true, the patient was high risk
for tuberculosis given his ethnicity, and therefore, actively search-
ing for tuberculosis early waswarranted. It was not until the patient
received anti-tuberculous medication alongside the standard
management that his ventricular function improved.
The optimal investigative modality for diagnosing TB early is yet
to be determined. Perhaps as Thachill et al. recommend, a combi-
nation of varied imaging techniques in conjunction with histo-
pathological analysis from endomyocardial and/or lymph node
biopsies will provide a higher diagnostic yield [6]. In situations
where an endomyocardial biopsy is inconclusive, as with our ﬁrst
patient, it is crucial to investigate for lymphadenopathy using PET
scanning or CMR to identify potential lymph nodes to biopsy using
EBUS [11]. In both our patients, it was not until EBUS-guided lymph
node biopsies were performed that a ﬁnal diagnosis of TB was
reached. As in our second patient, it is vital to analyse the biopsy for
histology and PCR genetic testing as well as culture since the
outcome may only be positive in one mode of analysis.
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CMR imaging to reveal lymphadenopathy [9]. CMR can also
demonstrate the best endomyocardial areas to biopsy. However,
where serial MR imaging is contraindicated following ICD insertion,
Uusimaa et al. suggest the use of LV-cineangiography, 201TI single-
photon-emission computed tomography, or multi-slice computed
tomography [11].
In conclusion, we describe two cases of tuberculosis presenting
as sustained monomorphic ventricular tachycardia. In both,
standard anti-arrhythmic therapies were unsuccessful and it was
only once anti-tuberculous chemotherapy was commenced
alongside ICD insertion that any clinical improvement was wit-
nessed. The diagnosis of TB myocarditis is a difﬁcult one to make.
It requires a high index of suspicion from the clinician and an
active diagnostic pursuit. This must include a multitude of imag-
ing techniques with the aim of identifying lymph nodes amenable
to biopsy via EBUS, or the use of endomyocardial biopsy. It is
possible that this condition has been historically underdiagnosed
but the improvements in diagnostic tools may now allow us to
fully appreciate the impact of this rare manifestation of a common
global disease.References
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